| Market Cap | ₹16Cr |
| ROE | 9.68% |
| P/E Ratio(TTM) | -10.68 |
| EPS(TTM) | -1.54 |
| P/B Ratio | 0.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 39.97 |
| Book Value | -15.82 |
| Debt to Equity | -1.35 |
| Face Value | 10 |
| Parent Organisation | Norris Medicines Limited |
| Managing Director | Vimal Dhirendra Shah |
| BSE Symbol | 524414 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 37.64 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 31.38 | ||
| Cohance Lifesciences | NA (0.00%) | 71.87 | ||
| Wockhardt | NA (0.00%) | -417.83 |